Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Phillip Maples, Catherine Moukheibir

Premium

Gradalis has promoted Phillip Maples as executive vice president and chief technical officer.

Maples joined the company as its first employee in 2005, and in his new role will continue to oversee product development, manufacturing, and quality assurance.

Before Gradalis, Maples held various roles at Baxter Healthcare, US Oncology, and CellExSys.


Therapeutic protein developer Ablnyx has appointed Catherine Moukheibir it is board of directors.

Moukheibir is currently a board member of Innate Pharma and an independent director of Creabilis. She previously served as vice president of Spanish RNAi drug developer Sylentis.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.